NASDAQ:CARA
Delisted

Cara Therapeutics Stock Signals

etoro logo Buy CARA
*Your capital is at risk
$5.32
+0 (+0%)
At Close: Jul 14, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Cara Therapeutics

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $5.32 0 %
Performance History
7 Days
$5.32 $5.32
0%
30 Days
$5.32 $5.32
0%
12 Mos
$12.69 $5.32
-58.08%

3/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $5.32 - $5.32
Trend - 3 mos 0 % High Width: 0.00000000000020 %
Pred. range - 3 mos $5.32 - $5.32 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jul 11, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low May 01, 2025 - 50 days
Short MA 3 mos Sell Low Apr 22, 2025 - 57 days
Long MA 3 mos Sell Medium Jun 02, 2025 - 29 days
Short/Long MA 3 mos Sell Medium Jun 02, 2025 - 29 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 17.32
Signal Type Signal Value Importance Data
Trend - 12 mos -25.77 % Very High Width: 328.55 %
Pred. range - 12 mos $2.69 - $11.52 High -49.46 % - 116.60 %
Short MA 12 mos Sell Very High May 12, 2025 - 43 days
Long MA 12 mos Sell Very High Jun 12, 2025 - 21 days
Short/Long MA 12 mos Sell Very High Jun 12, 2025 - 21 days
Pivot Long Buy Low Apr 15, 2025 - 61 days
RSI Long Pivot Signal Sell Low May 12, 2025 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CARA THERAPEUTICS
Cara Therapeutics
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE